(Q36922233)

17 August 2017

1 reference

title

B-cell targeting: a novel approach to immune intervention today and tomorrow (English)

1 reference

17 August 2017

Thomas Dörner

1

1 reference

17 August 2017

Peter E Lipsky

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

Expert Opinion on Biological Therapy

17 August 2017

published in

1 reference

17 August 2017

volume

7

1 reference

17 August 2017

issue

9

1 reference

17 August 2017

page(s)

1287-1299

1 reference

Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Pathogenic roles of B cells in human autoimmunity; insights from the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Human innate B cells: a link between host defense and autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

B-cell memory: are subsets necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Autoreactivity by design: innate B and T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Competence and competition: the challenge of becoming a long-lived plasma cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Antigen-specific memory B cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Textbook germinal centers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Predominant autoantibody production by early human B cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Cellular and genetic mechanisms of self tolerance and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Defective B cell tolerance checkpoints in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Impaired early B cell tolerance in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Molecular basis of immunoglobulin variable region gene usage in systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Autoreactivity in human IgG+ memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

The central and multiple roles of B cells in lupus pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Comparison of immunoglobulin heavy chain rearrangements between peripheral and glandular B cells in a patient with primary Sjögren's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

B cells in rheumatoid synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

B-cell targeting in rheumatoid arthritis and other autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

An open study of B lymphocyte depletion in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Measurement of radiographic joint space width in the tibiofemoral compartment of the osteoarthritic knee: comparison of standing anteroposterior and Lyon schuss views

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Depletion of B cells by a humanized anti-CD20 antibody PRO70769 in Macaca fascicularis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Marginal zone B cells in lymphocyte activation and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Defective B1 cell homing to the peritoneal cavity and preferential recruitment of B1 cells in the target organs in a murine model for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Epitope specificity of the anti-(B cell lymphoma) monoclonal antibody, LL2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

BCMA is essential for the survival of long-lived bone marrow plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

T cell-independent somatic hypermutation in murine B cells with an immature phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

CD40/CD154 interactions at the interface of tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

CD19 regulates B cell maturation, proliferation, and positive selection in the FDC zone of murine splenic germinal centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Block and tackle: CTLA4Ig takes on lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Interleukin-6: discovery of a pleiotropic cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Interleukin-6 and rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Gene expression profiling in human autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

An etiopathogenic role for the type I IFN system in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Systemic lupus erythematosus and the type I interferon system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Autoimmunity through cytokine-induced dendritic cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Fcgamma receptors: old friends and new family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

The inhibitory Fcγ receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Inhibition of allergen-specific IgE reactivity by a human Ig Fcgamma-Fcepsilon bifunctional fusion protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Tolerability and safety of rituximab (MabThera).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Adaptation of humoral memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

Relapse of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.9.1287

10.1517/14712598.7.9.1287

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference